Semaglutide Treatment in Type 1 Diabetes
Semaglutide Treatment in Type 1 Diabetes
Not yet recruiting · NCT06909006 · Registry updated 2025-08-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Semaglutide Treatment in Type 1 Diabetes | Body Weight, Body Weight Changes, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, immune system disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 1 diabetes mellitus | Not yet recruiting | Phase 3 | 2025-08-08 | NCT06909006 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aarhus University Hospital | 297 |
| Nordsjaellands Hospital | 40 |
| Steno Diabetes Center Copenhagen | 41 |
| Steno Diabetes Center Odense | 10 |
| Zealand University Hospital | 96 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nordsjaellands Hospital | Hillerød | Denmark | 1 |